Ftse Mib
33.260,13
0,51%
DAX
19.425,73
0,85%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
96.483,83
0,86%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito AQSE HUTCHMED China Limited (HCM.GB) HUTCHMED China Limited (HCM.GB) Notizie

HCM.GB

HUTCHMED China (HCM.GB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AQSE:HCM.GB
DataOraFonteTitoloSimboloCompagnia
29/12/202309:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
29/12/202309:30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnAQSE:HCM.GBHUTCHMED China Limited
21/12/202311:00UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementAQSE:HCM.GBHUTCHMED China Limited
09/11/202308:00UK RegulatoryHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib)AQSE:HCM.GBHUTCHMED China Limited
24/10/202310:30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPAQSE:HCM.GBHUTCHMED China Limited
14/09/202310:30UK RegulatoryHutchmed (China) Limited Director's Share DealingAQSE:HCM.GBHUTCHMED China Limited
21/08/202308:00UK RegulatoryHutchmed (China) Limited Sovleplenib Phase 3 Study Meets Primary EndpointAQSE:HCM.GBHUTCHMED China Limited
07/08/202310:30UK RegulatoryHutchmed (China) Limited Exercise of Share Options by a DirectorAQSE:HCM.GBHUTCHMED China Limited
31/07/202313:00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesAQSE:HCM.GBHUTCHMED China Limited
13/07/202310:30UK RegulatoryHutchmed (China) Limited Changes to Board and Technical CommitteeAQSE:HCM.GBHUTCHMED China Limited
26/06/202310:30UK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year ResultsAQSE:HCM.GBHUTCHMED China Limited
16/06/202308:00UK RegulatoryHutchmed (China) Limited Phase III FRESCO-2 Results in The LancetAQSE:HCM.GBHUTCHMED China Limited
15/06/202316:39UK RegulatoryHutchmed (China) Limited MAA of Fruquintinib Validated by the EMAAQSE:HCM.GBHUTCHMED China Limited
06/06/202311:00UK RegulatoryHutchmed (China) Limited LTIP and Share Option SchemeAQSE:HCM.GBHUTCHMED China Limited
26/05/202308:00UK RegulatoryHutchmed (China) Limited Fruquintinib NDA Granted Priority Review by FDAAQSE:HCM.GBHUTCHMED China Limited
17/05/202310:30UK RegulatoryHutchmed (China) Limited Standard form for notification of major holdingsAQSE:HCM.GBHUTCHMED China Limited
12/05/202314:15UK RegulatoryHutchmed (China) Limited Annual General Meeting Poll ResultsAQSE:HCM.GBHUTCHMED China Limited
12/05/202310:30UK RegulatoryHutchmed (China) Limited Board of Directors and Board Committee MembershipAQSE:HCM.GBHUTCHMED China Limited
10/05/202310:30UK RegulatoryHutchmed (China) Limited Appointment of Independent NEDAQSE:HCM.GBHUTCHMED China Limited
11/04/202310:30UK RegulatoryHutchmed (China) Limited 2022 Annual Report and Notice of AGMAQSE:HCM.GBHUTCHMED China Limited
11/04/202310:30UK RegulatoryHutchmed (China) Limited Intended Retirement of Independent NEDAQSE:HCM.GBHUTCHMED China Limited
28/02/202309:30UK RegulatoryHutchmed (China) Limited 2022 Full Year Results and Business UpdatesAQSE:HCM.GBHUTCHMED China Limited
31/01/202309:30UK RegulatoryHutchmed (China) Limited Notice of ResultsAQSE:HCM.GBHUTCHMED China Limited
23/01/202309:00UK RegulatoryHutchmed (China) Limited License to Takeda for Fruquintinib outside ChinaAQSE:HCM.GBHUTCHMED China Limited
18/01/202315:30UK RegulatoryHutchmed (China) Limited Inclusion of ORPATHYS in NRDL in ChinaAQSE:HCM.GBHUTCHMED China Limited
15/11/202208:00UK RegulatoryHutchmed (China) Limited HUTCHMED Announces Strategy UpdateAQSE:HCM.GBHUTCHMED China Limited
14/11/202208:00UK RegulatoryHutchmed (China) Limited Positive Topline Phase 3 Result in FruquintinibAQSE:HCM.GBHUTCHMED China Limited
14/09/202212:00UK RegulatoryHutchmed (China) Limited Share Option Scheme and Long Term Incentive PlanAQSE:HCM.GBHUTCHMED China Limited
08/09/202208:00UK RegulatoryHutchmed (China) Limited FRESCO-2 Colorectal Cancer MRCT Data HighlightsAQSE:HCM.GBHUTCHMED China Limited
23/08/202211:00UK RegulatoryHutchmed (China) Limited Holding(s) in CompanyAQSE:HCM.GBHUTCHMED China Limited
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AQSE:HCM.GB

La tua Cronologia

LSE
UBLA
Utd.bk (144a)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network